Biomea Fusion, Inc. logo

Biomea Fusion, Inc.

NASDAQ:BMEA

Overview | Financials
Company Name Biomea Fusion, Inc.
Symbol BMEA
Currency USD
Price 5.16
Market Cap 185,474,136
Dividend Yield 0%
52-week-range 3.61 - 23.07
Industry Biotechnology
Sector Healthcare
CEO Mr. Thomas Andrew Butler
Website https://biomeafusion.com

An error occurred while fetching data.

About Biomea Fusion, Inc.

Biomea Fusion, Inc., a biopharmaceutical company, focuses on the discovery and development of covalent small molecule drugs to treat patients with genetically defined cancers and metabolic diseases. Its lead product candidate is BMF-219, an orally bioavailable, potent, and selective covalent inhibitor of menin, a transcriptional regulator in oncogenic signaling in

Related Stocks

Longeveron Inc. logo

Longeveron Inc.

LGVN

3.25 USD

Chimerix, Inc. logo

Chimerix, Inc.

CMRX

0.9 USD

Harvard Bioscience, Inc. logo

Harvard Bioscience, Inc.

HBIO

3.18 USD

OptiNose, Inc. logo

OptiNose, Inc.

OPTN

1.08 USD

Inozyme Pharma, Inc. logo

Inozyme Pharma, Inc.

INZY

5.32 USD

High Tide Inc. logo

High Tide Inc.

HITI

1.83 USD

Omeros Corporation logo

Omeros Corporation

OMER

4.88 USD

Financials

Numbers are in millions USD

Numbers are in millions USD